FdaApplication
BLA 021839
Identifiers
- fda_app_no: BLA021839
Properties
| Property | Value |
|---|---|
| applicant_name | Eton Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2005-08-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INCRELEX | MECASERMIN RECOMBINANT | 40MG/4ML (10MG/ML) | Injection |
1 product